These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 13830930

  • 1. Uricosuric agents in the treatment of gout.
    KERSLEY GD, GIBBS AR.
    Ann Rheum Dis; 1960 Dec; 19(4):351-5. PubMed ID: 13830930
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Uricosuric agents in the management of chronic tophaceous gout with renal impairment.
    MORRIS JB.
    N Z Med J; 1961 Aug; 60():390-2. PubMed ID: 14476250
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of a uricosuric agent associated with the thermal diuresis treatment on uricemia and the excretion of uric acid in 50 hyperuricemic gout patients. Comparison of the action in patients with simple gout and trophic gout].
    MUGLER A.
    Rein Foie; 1961 Aug; 2():147-60. PubMed ID: 14476992
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W, Zöllner N.
    Postgrad Med J; 1979 Aug; 55 Suppl 3():26-31. PubMed ID: 504037
    [Abstract] [Full Text] [Related]

  • 8. [Gout. Clinical aspects, pathogenesis, current treatment].
    Galmiche P.
    Cah Med; 1971 Apr 30; 12(6):403-13. PubMed ID: 4934051
    [No Abstract] [Full Text] [Related]

  • 9. The Utility of the Random Urine Uric Acid-to-Creatinine Ratio for Patients with Gout Who Need Uricosuric Agents: Retrospective Cross-Sectional Study.
    Choi ST, Song JS, Kim SJ, Kim CH, Moon SJ.
    J Korean Med Sci; 2020 Apr 06; 35(13):e95. PubMed ID: 32242346
    [Abstract] [Full Text] [Related]

  • 10. The treatment of hyperuricemia in gout.
    Rastegar A, Thier SO.
    Ration Drug Ther; 1974 Mar 06; 8(3):1-4. PubMed ID: 4820829
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pathogenesis and therapy of gout].
    Mertz DP.
    Med Klin; 1971 Apr 23; 66(17):623-6. PubMed ID: 4994876
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Editorial: Therapy of gout nowadays (author's transl)].
    Mertz DP.
    Schweiz Rundsch Med Prax; 1974 Oct 08; 63(40):1185-7. PubMed ID: 4445089
    [No Abstract] [Full Text] [Related]

  • 15. [2-PHENYL-5-BROMO-1,3-INDANEDIONE IN THE URICOSURIC TREATMENT OF GOUT AND URIC ACID DIATHESIS].
    PASERO G, RICCIONI N.
    Clin Ter; 1963 Jul 15; 26():32-44. PubMed ID: 14050034
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N, Griebsch A, Fink JK.
    Dtsch Med Wochenschr; 1970 Nov 27; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract] [Full Text] [Related]

  • 17. [Diet therapy in gout].
    Dreyfus P, Six B, Forette B.
    Sem Hop; 1969 Nov 14; 45(46):2899-903. PubMed ID: 4313098
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F, Saporta L, de Géry A, Jabre E.
    Rev Rhum Mal Osteoartic; 1970 Nov 14; 37(6):443-50. PubMed ID: 5453852
    [No Abstract] [Full Text] [Related]

  • 20. [TREATMENT OF GOUT WITH URACIL-6-CARBOXYLIC ACID AND ITS DERIVATIVES].
    DELBARRE F, AUSCHER C.
    Presse Med (1893); 1963 Sep 14; 71():1765-8. PubMed ID: 14091585
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.